Electronic decision support for deprescribing (MedSafer tool) for Deprescribing (E-CARE Trial)

N/A

Waitlist Available

Led By Emily McDonald, MDCM

Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

No Placebo-Only Group

Summary

This trial tests an electronic tool called MedSafer, which helps doctors and nurses in aged care facilities safely reduce or stop unnecessary medications for older adults. The tool analyzes patient information and provides real-time reports on which medications can be safely adjusted. This helps healthcare providers manage complex medication regimens more effectively.

Eligible Conditions

Deprescribing
Overmedication
Adverse Drug Reactions

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Proportion of patients with one or more PIM (potentially inappropriate medication) reduced or stopped

Secondary study objectives

Sustainability; quality of life; sleep quality; falls; transfer to acute hospital; hip fractures; and delirium

Other study objectives

Cost savings

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention: MedSaferExperimental Treatment1 Intervention

In the intervention phase, the MedSafer feature will become accessible in MED e-care for the physicians, pharmacists and nurses. This feature will provide health care professionals with individualized and prioritized deprescribing opportunities: a) identifying the medication, b) explaining why that medication is potentially inappropriate and c) providing instructions on how to safely stop/taper the medication. The user will review these opportunities and appropriate candidate medications for deprescribing can then be tapered or stopped directly in the EMR. During the intervention phase, all patients will receive the educational (EMPOWER) brochures as applicable to the medications they are taking (PPI, sedative-hypnotic, antihistamine, antipsychotic, sulfonylurea, NSAID, opioid/narcotic).

Group II: Control: Baseline (no MedSafer)Active Control1 Intervention

During the control phase, the MedSafer application programming interface will not be accessible to the caretakers at the aged care facilities (ACF). This serves to obtain baseline deprescribing levels for each ACF.

Do I qualify?Apply below to find out